Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 451,678 | 363,376 | 372,528 | 402,434 | 394,761 |
| Marketable Securities | 283,808 | 211,279 | 193,543 | 181,123 | 119,667 |
| Receivables | 22,981 | 49,817 | 45,245 | 23,667 | 27,650 |
| Inventories | 12,975 | 9,986 | 14,113 | 16,316 | 18,133 |
| Income taxes - deferred | 83,438 | 68,192 | 70,714 | 81,536 | 91,824 |
| TOTAL | $900,838 | $738,148 | $725,487 | $739,312 | $691,869 |
| Non-Current Assets | |||||
| PPE Net | 92,178 | 90,577 | 86,895 | 84,809 | 87,915 |
| Investments And Advances | 205,938 | 289,745 | 244,535 | 198,371 | 180,996 |
| Intangibles | 343,156 | 332,276 | 304,766 | 323,401 | 333,416 |
| Other Non-Current Assets | 39,205 | 58,003 | 62,217 | 55,319 | 41,950 |
| TOTAL | $680,477 | $770,601 | $698,413 | $661,900 | $644,277 |
| Total Assets | $1,581,315 | $1,508,749 | $1,423,900 | $1,401,212 | $1,336,146 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,624 | 1,615 | 1,540 | 1,527 | 1,593 |
| Accounts payable and accrued liabilities | 12,921 | 8,184 | 10,060 | 11,060 | 10,137 |
| Accrued Expenses | 100,901 | 102,525 | 109,576 | 118,028 | 146,788 |
| TOTAL | $156,584 | $148,331 | $147,932 | $191,247 | $200,673 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,825 | 6,315 | 6,453 | 6,887 | 7,782 |
| Deferred Revenues | 37,204 | 35,110 | 25,372 | 39,481 | 37,344 |
| Other Non-Current Liabilities | 31,065 | 51,004 | 52,378 | 53,653 | 55,512 |
| TOTAL | $61,626 | $83,751 | $80,873 | $82,817 | $86,220 |
| Total Liabilities | $218,210 | $232,082 | $228,805 | $274,064 | $286,893 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,026 | 113,562 | 113,058 | 112,744 | 112,581 |
| Common Shares | 113 | 113 | 113 | 112 | 112 |
| Retained earnings | 852,475 | 808,176 | 757,030 | 687,579 | 609,495 |
| Other shareholders' equity | 31,538 | 2,081 | -11,962 | -3,778 | 4,739 |
| TOTAL | $1,363,105 | $1,276,667 | $1,195,095 | $1,127,148 | $1,049,253 |
| Total Liabilities And Equity | $1,581,315 | $1,508,749 | $1,423,900 | $1,401,212 | $1,336,146 |